Prime Medicine, Inc. ( (PRME) ) has released its Q3 earnings. Here is a breakdown of the information Prime Medicine, Inc. presented to its ...

Investment analysts at HC Wainwright decreased their FY2024 earnings per share (EPS) estimates for Prime Medicine in a ...

Prime Medicine, Inc. (PRME – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst ...

On Monday, Prime Medicine Inc (PRME) stock saw a modest uptick, ending the day at $4.39 which represents a slight increase of $0.29 or 7.07% from the prior close of $4.1. The stock opened at $4.23 and ...

So, the natural question for Prime Medicine (NASDAQ:PRME) shareholders is whether they should be concerned by its rate of cash burn. For the purposes of this article, cash burn is the annual rate ...

Replays of each webcast will be available on the Prime Medicine website for 90 days following the event. Prime Medicine is a leading biotechnology company dedicated to creating and delivering the next ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

CAMBRIDGE, Mass., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic ...

CAMBRIDGE, Mass., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic ...